Monte Rosa Therapeutics, Inc. (GLUE) Operating income 2020–2025
Monte Rosa Therapeutics, Inc. (GLUE) annual operating income history from SEC filings — each fiscal year as reported.
-$54.2MFY2025 · since FY2020: -$28.0M → -$54.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$54.2M | +33.2% |
| FY2024 | -$81.1M | +43.4% |
| FY2023 | -$143.3M | -27.5% |
| FY2022 | -$112.4M | -54.2% |
| FY2021 | -$72.9M | -160.2% |
| FY2020 | -$28.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice